Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.4c05221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Lian-Hua Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engin…. Hauptthemen laut MEDLINE: Osteoporosis, Glucose Oxidase, Catalase, Diabetes Complications. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Planning Project of Shenzen Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic osteoporosis (DOP) is a chronic complication of diabetes mellitus (DM) that impairs bone health, and effective management of DOP remains a formidable challenge. In this study, we developed a biocatalytic cascade nanoplatform, GOx@SrCaP-CAT-Tet, offering osteogenic, angiogenic, and anti-inflammatory activities for targeted DOP management. The platform includes glucose oxidase (GOx) and catalase (CAT), encapsulated in strontium-doped calcium phosphate (SrCaP), converting glucose into gluconic acid and hydrogen peroxide (H2O2), alleviating the hyperglycemia and promoting hypoxia-induced vascularization. Both the generated H2O2 and any overabundance of H2O2 in the DOP microenvironment can be scavenged by CAT, thus relieving inflammation. Via a surface modified with tetracycline (Tet) for bone targeting, the release of Sr2+, Ca2+, and PO43- can stimulate osteogenesis and suppress osteoclastogenesis, thereby hastening bone formation and reversing osteoporosis. This nanoplatform shows promise in managing DOP both in vitro and in vivo. Our findings open a new horizon for managing DOP through biocatalytic cascade reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenz…
- Department of Plastic and Reconstructive Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
- Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325000, China.
- The Third Affiliated Hospital of Xinxiang Medical University, Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang, Henan 453003, China.
- National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Ministry of Education, Department of Orthopedics and Trauma, Peking University People's Hospital, Beijing 100044, China.
- Shenzhen University General Hospital, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong 518055, China.
ORCID-Profile: Chen Yang, Jing Lin, Peng Huang
Förderung
- National Key Research and Development Program of China
- Science and Technology Planning Project of Shenzen Municipality
- National Natural Science Foundation of China
- Shenzhen University
- Shenzhen Medical Research Fund
Zitieren
APA
Fu, L. H., Yin, M., Chen, X., Yang, C., Lin, J., Wang, X., Jiang, B., & Huang, P. (2025). Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c05221
Vancouver
Fu LH, Yin M, Chen X, Yang C, Lin J, Wang X, et al. Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform. Nano Letters. 2025. doi:10.1021/acs.nanolett.4c05221
BibTeX
@article{Fu2025,
author = {Fu, Lian-Hua and Yin, Mengting and Chen, Xin and Yang, Chen and Lin, Jing and Wang, Xiansong and Jiang, Baoguo and Huang, Peng},
title = {Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.4c05221}
}
EUVIMED